De Aller-Bedste Bøger - over 12 mio. danske og engelske bøger
Levering: 1 - 2 hverdage

Pharma M&A versus alliances and its underlying value drivers

- Are M&A or alliances the right therapy for an ailing pharmaceutical industry?- A capital market perspective

Bag om Pharma M&A versus alliances and its underlying value drivers

This study analyzes 229 M&A and 120 in-licensing deals in the pharmaceutical industry. The author shows from a capital market perspective that M&A experiences significant, negative cumulative average abnormal returns whereas in-licensings are able to create value. Significant determinants of success for both strategies are derived.

Vis mere
  • Sprog:
  • Engelsk
  • ISBN:
  • 9783631663813
  • Indbinding:
  • Hardback
  • Sideantal:
  • 201
  • Udgivet:
  • 28. september 2015
  • Udgave:
  • Størrelse:
  • 215x154x17 mm.
  • Vægt:
  • 362 g.
  • 2-3 uger.
  • 19. december 2024
På lager
Forlænget returret til d. 31. januar 2025

Normalpris

Abonnementspris

- Rabat på køb af fysiske bøger
- 1 valgfrit digitalt ugeblad
- 20 timers lytning og læsning
- Adgang til 70.000+ titler
- Ingen binding

Abonnementet koster 75 kr./md.
Ingen binding og kan opsiges når som helst.

Beskrivelse af Pharma M&A versus alliances and its underlying value drivers

This study analyzes 229 M&A and 120 in-licensing deals in the pharmaceutical industry. The author shows from a capital market perspective that M&A experiences significant, negative cumulative average abnormal returns whereas in-licensings are able to create value. Significant determinants of success for both strategies are derived.

Brugerbedømmelser af Pharma M&A versus alliances and its underlying value drivers



Find lignende bøger
Bogen Pharma M&A versus alliances and its underlying value drivers findes i følgende kategorier: